The Centers for Medicare & Medicaid Services should determine the extent to which state Medicaid programs comply with federal requirements to cover medication-assisted treatment in all formats, and take actions as appropriate to ensure compliance, the Government Accountability Office said in a report released today. Congress asked GAO to review access barriers to MAT medications. GAO found that some state policies, such as prior authorization requirements and mandated distribution methods, can restrict Medicaid beneficiaries' access to MAT. 

Related News Articles

Headline
The Health Resources and Services Administration Aug. 20 announced  $1.4 billion in program funding for individuals with HIV who have low incomes to…
Headline
Two clinicians and a vehicle — that's the model Sheppard Pratt has been using to give behavioral health access to its communities. In this conversation, Jason…
Headline
The Centers for Medicare & Medicaid Services Aug. 15 released a state funding notice for the Cell and Gene Therapy Access Model. The CGT Access Model will…
Headline
The Centers for Medicare & Medicaid Aug. 15 announced it negotiated lower prices with drug makers for 10 high-cost, sole-source drugs, with the new prices…
Headline
Mary Thompson — a member of AHA’s Committee on Behavioral Health and president of Trillium Place, a mental health and addiction recovery organization…
Blog
More than 16 years ago, the U.S. House of Representatives designated July as National Minority Mental Health Awareness Month. Inspired by the work of author…